Trials / Completed
CompletedNCT02995148
Sun Protection Factor Assay (343/2016)
Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment-Darkening Dose (MPPD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the Sun Protection Factor efficacy on human skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY987521 | Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application. (Formulation Code: Z43-104) |
| DRUG | SPF Control | Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application. |
Timeline
- Start date
- 2016-12-30
- Primary completion
- 2017-01-06
- Completion
- 2017-01-06
- First posted
- 2016-12-16
- Last updated
- 2018-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02995148. Inclusion in this directory is not an endorsement.